Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 21 July 2020

Tuesday, 21 July 2020

Ceisteanna (673)

Róisín Shortall

Ceist:

673. Deputy Róisín Shortall asked the Minister for Health if he will engage with an organisation (details supplied) regarding the use of sodium valproate in pregnancy; his plans to hold an inquiry into the use of the drug; the actions he is taking to support families affected by foetal valproate syndrome; and if he will make a statement on the matter. [16907/20]

Amharc ar fhreagra

Freagraí scríofa

On 8 July, the Independent Medicines and Medical Devices Safety Review in the UK published its report into sodium valproate and two other medical interventions. I have asked officials in my Department, as well as in the HSE and the Health Products Regulatory Authority, to consider the findings of this report and provide me with comprehensive briefing before I consider the next steps in addressing the issue of sodium valproate use in Ireland. This will include consideration of requests to meet patient organisations and other stakeholders.

Question No. 674 answered with Question No. 672.
Barr
Roinn